Raffles Medical share price in magical comeback!
What a comeback! Following the release of a set of stellar 1HFY2022 financial result, Raffles Medical share price soared 17% within a week. The recovery of Raffles Medical share price must be surreal for investors as the counter collapsed spectacularly in February 2022 following the release of a set of decent financial result for FY2021.
The bearish form of Raffles Medical share price in late 2021 was attributed to the change in the COVID-19 test policy. Raffles Medical share (SGX: BSL) had ridden on the pandemic wave as the Group provides PCR swab tests services. Then again, it is always a risky business to pivot a business on pandemic measures.
In early 2022, Raffles Medical share price came under further pressure due to the lockdowns in China cities, which impacted the Group’s three hospitals in China. According to the management, Raffles Hospital Shanghai was the most impacted. To cushion the impact, the Group conducted a series of shares buybacks to rescue Raffles Medical share price. For the new financial year, the Group acquired 5.3 million of shares from the market. As at 28 June, the number of treasury shares held was 23.3 million.
Here’s why Raffles Medical share price plunged 12%
Raffles Medical share price in sensational return!
Read More